Moreover, some of the proposed drugs are potentially effective on pharmacological targets already identified as potential drug targets or under investigation in ongoing clinical trials on COVID-19 patients (i.e., VEGFA, C1QA, C1QB, and C1QC)8. This evidence concerns the gene C1QB and COVID-19.